What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Daxor Corporation

Home
United States
Oak Ridge, TN
Daxor Corporation

Committed to advancing the field of healthcare by enabling optimal fluid management with blood volume analysis. (Nasdaq: $DXR)

06/18/2026

Why is evaluating syncope one of the most frustrating scenarios in cardiology?

Because different underlying conditions present with identical symptoms.

It all comes down to a fundamental medical equation:

Pressure = Volume × Systemic Vascular Resistance (SVR)

Standard vitals only give doctors the Pressure, leaving them with two hidden variables. Without knowing whether a root cause is a Volume problem or a Resistance problem, clinicians are faced with competing clinical interpretations.

Blood Volume Analysis (BVA) solves for volume, measuring one of the hidden variables to inform care and unlock a pathway forward.

Read more how BVA acts as the ultimate front-end screening tool in this month’s BVA Brief: https://www.linkedin.com/pulse/syncope-unmasking-hidden-variables-bva-daxorcorporation-3nrve/

06/12/2026

The Daxor team is thrilled to welcome our new Senior Vice President of Commercialization, Annette Plishka BSN, MSA! Annette brings exactly what needs for our next phase of growth: a powerful blend of commercial strategy and hands-on clinical insight.

As a former Captain in the U.S. Air Force Nurse Corps and a registered nurse, Annette understands the bedside realities that healthcare providers face daily. At Daxor, she will lead our commercial scaling, helping clinicians across all healthcare settings dismantle clinical inertia and adopt Blood Volume Analysis ( ) as the standard of care for precision fluid management.

Her unique ability to translate complex diagnostic data into actionable care pathways will be a tremendous asset to our partners and the patients we serve.

Welcome to the team, Annette! 🚀

06/09/2026

Daxor’s Senior VP of Marketing and Commercial Development, Kathryn Kornafel, attended the 2026 Duke Health University Heart Failure Symposium this weekend, where leading experts shared the latest developments in therapies and patient management.

Dr. Marat Fudim’s presentation, "Remote Monitoring in Heart Failure" highlighted a case report published in ESC Heart Failure examining the relationship between volume ( ) and pressure.

A key takeaway is that pressure-based assessments of congestion in ambulatory heart failure patients do not always accurately reflect intravascular volume, reinforcing an important clinical distinction: pressure and volume are not the same.

You can find the full study here: https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.14219

Important Safety Information:
- The Daxor BVA™ and Volumex® are Rx Only and intended for use in adults by qualified, CLIA-certified professionals
- Safety and effectiveness has not been established in pediatric, pregnant, or nursing patients
- This information is for educational purposes only and is not a substitute for professional medical advice or a promotion of off-label use

06/04/2026

Today we’re featuring our Vice President of Grants and Contracts, Noa Kohl!

Noa is a trained cellular and molecular biologist with research experience at the Weizmann Institute of Science and Weill Cornell Medical School. She brings over a decade of experience in assisting life science organizations secure non-dilutive funding from U.S. federal agencies and private foundations.

In her 7 years on the team, Noa has developed a robust portfolio of grants and contracts to support the development and validation Daxor’s technologies.

06/02/2026

Daxor announces that the United States Patent and Trademark Office has issued U.S. Patent No. 12,635,917 B2, titled “Remote Blood Volume Monitor,” expanding the company’s diagnostic capabilities to enable continuous, remote tracking of status using .

This patent represents significant progress in personalized, remote patient care , , , and .

Full press release here: https://daxor.com/daxor-corporation-receives-u-s-patent-for-breakthrough-remote-blood-volume-monitor/

05/28/2026

As National Critical Care Awareness and Recognition Month comes to a close, proudly honors the extraordinary dedication of and doctors. In the , every second counts, and your unwavering commitment to patient care saves lives daily.

Society of Critical Care Medicine (SCCM)

05/20/2026

Today we’re featuring Daxor's Vice President of Development and Operations, Linda Cooper!

With over 35 years of expertise, Linda leads our Oak Ridge headquarters—the nerve center for all Daxor operations. By overseeing both manufacturing and R&D, she drives our next-generation product development to ensure the future of technology is rooted in precision and innovation.

05/13/2026

The JACC Journals published a Clinical Case Series that highlighted how 's blood volume analysis ( ) uncovered a hidden polycythemia subtype in nearly 20% of patients.

Our patented, U.S. Food and Drug Administration-cleared diagnostic was found to detect critical volume issues missed by standard blood tests that drive patient outcomes, including higher and blood clot risks and a high incidence of polycythemia, which poses additional clinical challenges for patients if untreated.

Learn more: https://www.jacc.org/doi/10.1016/j.jaccas.2024.103077

Banner Health

05/12/2026

Stop chasing the "Creatinine Bump"! 🛑

By the time serum creatinine rises, the injury has often already occurred. We are looking at a "rearview mirror" of renal health. 📈

With AKI-related mortality rising by over 150% in certain patient populations recently (CDC WONDER, 2025), reactive medicine isn't enough. 🆘

🔗Read more in this month’s BVA Brief: https://www.linkedin.com/pulse/stop-waiting-creatinine-bump-proactive-aki-prevention-c1kle/

04/30/2026

You’re ready to titrate GDMT. You’ve done everything right. But do you actually know your patient’s volume status? Without objective BVA data, you might be fighting a losing battle.

Get the full insights in our CMO's latest "In The Know" update. https://www.linkedin.com/pulse/guidelines-arent-problem-your-data-daxorcorporation-s9edf/?trackingId=zsWGDsNHT9%2BXh41S3KJXUg%3D%3D

Address

107 Meco Lane
Oak Ridge, TN
37830

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

https://www.daxor.com/

Alerts

Be the first to know and let us send you an email when Daxor Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Daxor Corporation:

Shortcuts

Want your business to be the top-listed Health & Beauty Business in Oak Ridge?